Chaos Industries
Series C in 2025 
Chaos Industries is a technology company focused on defense and critical industries, developing advanced sensing, detection, and communication capabilities. It leverages Coherent Distributed Networks to enhance sensing, detection, and communication across platforms and emphasizes time synchronization to enable highly mobile, scalable, and cost-efficient systems. The company delivers integrated, software-defined solutions for defense, government, and industrial applications in challenging environments.
Vori Health
Series B in 2025 
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.
Metronome
Series C in 2025 
Metronome provides billing infrastructure for software companies, facilitating rapid deployment, flexibility, and user-friendly solutions. It enables business and product teams to manage revenue and pricing independently, streamlining workflows and offering customers real-time spending insights.
Abcuro develops immunotherapies targeting autoimmunity and cancer. Founded in 2015, the company uses bioinformatics and ex-vivo validation to uncover novel immune system targets.
Tune Therapeutics
Series B in 2025 
Tune Therapeutics develops cell and gene therapies guided by epigenetic programming to treat devastating diseases. The company is building an epigenetic programming platform that enables new pathways for disease treatment by tapping into the epigenome to program biology without altering the DNA sequence. This approach aims to deliver paradigm-changing therapies by modulating gene expression through epigenetic mechanisms rather than editing the genome, expanding options for diseases where conventional treatments have limited efficacy. By integrating epigenetics and cell biology, the company seeks durable, precise interventions that can reprogram cellular states to restore function while minimizing genetic change. The emphasis is on research and development to advance candidates toward clinical use to address severe and unmet medical needs.
Sana Labs is a leader in applying artificial intelligence to enhance educational outcomes through personalized learning. The company collaborates with prominent organizations to develop its innovative learning platform, which leverages advanced machine learning techniques. This platform is designed to empower education companies and integrates seamlessly with various applications, allowing employees to access knowledge, communicate, and automate tasks effectively. By offering insights into team strengths, weaknesses, and progress, Sana enables institutions in sectors such as healthcare, finance, and pharmaceuticals to improve their workforce's performance and learning experiences. The interdisciplinary team at Sana comprises experts from diverse fields, contributing to its mission of transforming the future of education.
Pathos develops an AI-enabled drug discovery platform aimed at reducing the medication development process. Its self-learning platform uses big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy, enabling drug developers to explore novel concepts and advance breakthrough therapies for various diseases.
858 Therapeutics
Series B in 2024 
858 Therapeutics is a biotechnology company specializing in the discovery of small molecule therapeutics for novel targets in oncology and immunology. The company focuses on innovative approaches such as synthetic lethality, innate immunity, and RNA modulation, with its lead program being a PARG inhibitor currently in early clinical development.
Second Front Systems
Series C in 2024 
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.
PayZen is a healthcare fintech company that helps patients manage out-of-pocket medical expenses by offering flexible, transparent payment plans and non-recourse financing. The platform enables patients to pay bills over time while helping providers accelerate cash flow and reduce costly collections. It uses AI-powered risk assessment to tailor each plan to the individual patient, supporting affordable payments without upfront burden. Founded in 2019 in San Francisco by Ariel Rosenthal, Itzik Cohen, and Tobias Mezger, PayZen aims to reduce financial barriers to care while enabling providers to focus on delivering services.
MBX Biosciences
Series C in 2024 
MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.
Cardurion Pharmaceuticals
Series B in 2024 
Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.
Zenas BioPharma
Series C in 2024 
Zenas BioPharma is a clinical-stage biopharmaceutical company focused on developing immune-based therapies for autoimmune and immune-mediated diseases. Based in Florida, United States, the company advances biologic programs and aims to modulate B cell–driven pathology. Its lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb on B cells, thereby inhibiting harmful immune activity without depleting B cells.
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.
Beehiiv operates an email newsletter platform designed for creators. It facilitates the production, monetization, and expansion of newsletters while enhancing audience engagement and growth. The platform's direct engagement model reduces reliance on cookie-based data.
Perplexity
Venture Round in 2024 
Perplexity is an AI-driven search engine platform that combines large language models with traditional search engines. It uses natural language processing (NLP) and generative AI to provide conversational responses, bridging the gap between conventional search engines and interactive AI assistance.
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.
Inkitt operates an online community for writers and readers, offering a platform where authors can share and refine their work while gaining insights from readers. The company uses data-driven approaches to identify popular stories and publishes them across various media, aiming to create blockbuster franchises similar to Disney's model.
Metronome
Series B in 2024 
Metronome provides billing infrastructure for software companies, facilitating rapid deployment, flexibility, and user-friendly solutions. It enables business and product teams to manage revenue and pricing independently, streamlining workflows and offering customers real-time spending insights.
Comanche Biopharma
Series B in 2024 
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.
Perplexity
Series B in 2024 
Perplexity is an AI-driven search engine platform that combines large language models with traditional search engines. It uses natural language processing (NLP) and generative AI to provide conversational responses, bridging the gap between conventional search engines and interactive AI assistance.
Second Front Systems
Series B in 2023 
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.
Pair Eyewear
Series C in 2023 
Pair Eyewear, Inc. is a New York-based company that specializes in customizable eyeglasses for children. Founded in 2017 by Nathan Kondamuri and Sophia Edelstein, the company offers a unique approach to eyewear by providing base frames and interchangeable top frames that allow kids to express their personal style and interests. By combining functionality with creativity, Pair Eyewear transforms glasses from mere medical devices into a fun and engaging accessory for children. The company's direct-to-consumer model leverages an e-commerce platform, making the purchasing process convenient for parents while enhancing the overall experience for young wearers. Pair Eyewear is committed to offering quality, affordable glasses that are both stylish and practical, featuring hand-polished frames and shatterproof polycarbonate lenses.
Pulumi Corporation
Series C in 2023 
Founded in 2017, Pulumi Corporation operates an infrastructure-as-code platform for developing cloud software. It offers Pulumi SDK, an open-source tool enabling developers to create, deploy, and manage cloud applications and infrastructure using code. The company also provides a web console for collaborative delivery and management of cloud apps and infrastructure across public, private, or hybrid environments.
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.
Spyglass Pharma
Series C in 2023 
Spyglass Pharma specializes in developing innovative treatments for chronic eye diseases using advanced technologies. The company aims to deliver multiple drugs to address additional ophthalmic indications.
Instabase
Series C in 2023 
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.
Strive Health
Series C in 2023 
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.
Sana Labs is a leader in applying artificial intelligence to enhance educational outcomes through personalized learning. The company collaborates with prominent organizations to develop its innovative learning platform, which leverages advanced machine learning techniques. This platform is designed to empower education companies and integrates seamlessly with various applications, allowing employees to access knowledge, communicate, and automate tasks effectively. By offering insights into team strengths, weaknesses, and progress, Sana enables institutions in sectors such as healthcare, finance, and pharmaceuticals to improve their workforce's performance and learning experiences. The interdisciplinary team at Sana comprises experts from diverse fields, contributing to its mission of transforming the future of education.
Weaviate is a company that offers an open-source AI-native database and hybrid SaaS platform to build search and recommendation systems. Its vector search engine supports semantic search and integrates with applications via plugins and a console that helps understand data. The platform merges vector and keyword search to enable end-to-end AI-native application development, supporting synchronous, asynchronous, and multi-step data interactions.
Mojo Vision
Series C in 2023 
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes AI-driven assessments and personalized learning plans to provide targeted mentorship and facilitate skill development. By offering an objective analysis of workforce skills, Workera helps organizations identify and mobilize talent effectively. Its approach includes measuring skills at a granular level, allowing for hyper-personalized learning experiences that drive measurable results. This capability equips organizations with actionable data, enabling them to make informed decisions regarding talent acquisition, mobility, coaching, and mentoring, ultimately addressing the critical skills gap in today's rapidly evolving technological landscape.
Fabric8Labs
Series B in 2023 
Fabric8Labs, Inc. is a technology company founded in 2015 and located in La Jolla, California, specializing in non-thermal metal 3D printing. The company has developed a proprietary process that combines stereo-lithography and electro-deposition, providing an innovative alternative to traditional powder bed fusion technologies. This method eliminates the reliance on metal powders, vacuum chambers, and lasers, which significantly reduces manufacturing costs while enhancing material quality. Fabric8Labs' technology allows clients to use cartridges that simplify the additive manufacturing process and facilitate the safe disposal of used salt cartridges, thereby promoting efficiency and sustainability in metal 3D printing.
Crowdbotics
Series B in 2023 
Crowdbotics is an application development platform that provides an enterprise-grade solution for building, modernizing and deploying web and mobile applications. It offers a library of production-grade components and a network of on-call experts to help product managers translate ideas into working code, selecting effective components and workflows. The platform handles infrastructure, implementation, maintenance, operations, monitoring and security for the life of a project, and uses artificial intelligence to map application requirements to existing code modules while capturing business logic and developer intent. It supports modernization, onboarding and governance by integrating with current tools and infrastructure, enabling enterprises to modernize legacy systems, reduce development risk and improve engineering efficiency.
Outrider develops autonomous electric trucks and management software for logistics hubs. Its technology automates yard operations, enhancing safety and efficiency for large enterprises.
Escient Pharmaceuticals
Series C in 2022 
Escient Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, specializing in the development and manufacture of G protein-coupled receptor (GPCR)-targeted drugs aimed at treating neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, Escient focuses on harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs). The company aims to provide innovative therapies for a variety of conditions, including mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers facing these complex diseases.
Dandelion Energy
Series B in 2022 
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
MBX Biosciences
Series B in 2022 
MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.
Inversago Pharma
Series C in 2022 
Inversago Pharma Inc. is a preclinical-stage biotechnology company based in Montreal, Canada, specializing in the development of peripherally-restricted CB1 receptor inverse agonists aimed at treating various metabolic and fibrotic disorders. Founded in 2015, the company focuses on creating innovative therapies for conditions such as Prader-Willi syndrome, diabetes, and complications related to obesity. Its pipeline includes treatments for diabetic kidney disease, non-alcoholic steatohepatitis, and progressive fibrosis, including interstitial lung disease. Inversago Pharma aims to improve patient outcomes by offering new therapeutic options that target the underlying mechanisms of these diseases.
Theorycraft Games
Series B in 2022 
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki.
Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.
Ledgy develops a valuation tracking platform to manage equity capital and employee participation. The platform streamlines vesting plans, phantom programs, and numbered shares, digitizing equity management to provide entrepreneurs and shareholders with clear insights into their capital table, financing rounds, and exit talks. Founded in 2017 in Zurich, Switzerland, Ledgy supports startups and growing companies in planning and communicating equity arrangements for stakeholders.
Evident
Venture Round in 2022 
Evident is a global leader in business credentialing, operating in over 100 countries. Its platform connects insurers, enterprises, and businesses, verifying credentials to meet compliance standards using advanced AI technology.
Moximed develops and provides the Atlas System, an implantable joint unloader designed to alleviate pain and preserve mobility in patients with medial compartment knee osteoarthritis. Its outpatient treatment option aims to improve quality of life for those not responsive to other therapies or candidates for knee replacement.
Snowplow is an enterprise-grade event analytics platform that specializes in behavioral data management. It empowers data teams by providing tools to track, contextualize, validate, and model customer interactions on websites and applications. The platform integrates web analytics with various third-party data sources, allowing businesses to gain comprehensive insights into customer behavior. Snowplow's solutions facilitate customer journey analytics, marketing attribution, product analytics, and paywall optimization, addressing complex data challenges and enhancing overall data-driven decision-making for organizations.
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016 and headquartered in New York, Narmi provides a comprehensive platform that allows regional and community banks and credit unions to attract, engage, and retain customers effectively. The company’s applications facilitate account openings in under 2.5 minutes, while ensuring a secure and user-friendly experience through features such as fraud protection, multi-factor authentication, and transaction monitoring. In addition to banking applications, Narmi also offers services in website design, development, hosting, and content management, helping financial institutions create a dynamic and engaging digital presence.
Wonder is a technology company that develops an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games across devices seamlessly.
Lily AI
Venture Round in 2022 
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.
Super is a social commerce platform that enables leaders to become self-made entrepreneurs and builds logistics networks. The company features Superagen, an agent-led commerce group buying that enables community leaders to become retailers within their communities.
Assembled
Series B in 2022 
Assembled, Inc. is a workforce management platform based in San Francisco, California, founded in 2018. The company specializes in enhancing customer support operations for modern organizations by automating key processes such as contact forecasting, staffing calculations, and productivity reporting. Its platform allows teams to effectively forecast support volumes and develop appropriate staffing plans, eliminating the need for cumbersome spreadsheets and disparate internal tools. Assembled offers an intuitive team calendar that accommodates various time zones and specializations, integrating seamlessly with popular tools like Google Calendar and Slack to facilitate collaboration. Additionally, it provides visibility into support schedules and performance metrics, including response times, across all organizational levels. By streamlining these processes, Assembled empowers organizations to make informed decisions, ultimately improving their customer support capabilities.
Mashgin is a California-based developer of AI-driven self-checkout kiosks used in cafeterias, convenience stores, specialty and travel retail. The system uses computer vision, deep learning, and real-time 3D technology to recognize items and handle multiple items in a single scan, speeding up checkout. The kiosks are deployed at hundreds of locations and serve tens of thousands of customers daily.
Genies empowers individuals to create personalized digital avatars for expression across social media and messaging platforms. It offers tools for users to design avatars, avatar fashion lines, worlds, and interactive experiences, enabling brands to drive engagement through exclusive digital goods.
Built Robotics
Series C in 2022 
Built Robotics develops automation technology for the construction industry by turning heavy equipment into autonomous robots with AI-guided software that integrates sensors such as GPS, cameras, and Lidar. The systems retrofit onto earthmoving equipment to enable autonomous operation on job sites, supporting projects such as wind farms, oil and gas pipelines, mining, and housing developments, and they are used to automate repetitive tasks in solar projects to accelerate the transition to clean energy.
ForAllSecure
Series B in 2022 
ForAllSecure specializes in advanced fuzz testing solutions, leveraging patented technology from Carnegie Mellon University. It partners with Fortune 1000 companies across industries like aerospace and automotive to provide scalable, autonomous security testing that keeps pace with rapid development cycles and frequent deployments.
Timescale
Series C in 2022 
Timescale develops an open-source time-series SQL database, TimescaleDB, designed for scale and complex queries. It integrates directly into query planning and execution engines to optimize performance, enabling clients to organize, store, analyze, and interpret time-series and machine data.
Beyond Identity
Series C in 2022 
Beyond Identity, Inc. is a New York-based company that specializes in cloud-native passwordless identity management solutions. Founded in 2019, it aims to enhance digital security by replacing traditional passwords with secure, X.509-based certificates. This innovative approach creates a robust Chain of Trust, incorporating user and device identity along with a real-time assessment of device security for adaptive authentication and authorization. Beyond Identity's platform facilitates frictionless login experiences through biometric authentication and seamless integration with Single Sign-On (SSO) systems, catering to employees, contractors, and customers alike. By eliminating the use of passwords, the company helps organizations mitigate risks associated with credential-stuffing attacks and streamline their authentication processes, ultimately enabling greater business agility and cost efficiency.
Thunkable
Series B in 2022 
Thunkable is a United States-based no-code platform that enables users to create native mobile applications without writing code. It offers a drag-and-drop interface, built-in templates, and design elements to simplify app development, with online design and instant previews on devices. The platform supports cross-platform deployment to major mobile platforms and enables direct submission to the iOS and Android app stores, allowing individuals and developers to build functional apps without traditional coding.
FTX is a cryptocurrency exchange company that develops platforms for professional trading firms, offering intuitive interfaces suitable for both experienced traders and beginners. It supports quarterly and perpetual futures for all major cryptocurrencies, leveraged tokens, and OTC derivatives.
Founded in 2012, Virtru specializes in data security solutions. Its platform enables businesses to protect sensitive information throughout its lifecycle without compromising ease of use, supporting compliance and maintaining control over data.
Smartcar develops a platform that enables mobility businesses to integrate their apps with connected vehicles. Its API allows retrieval of vehicle data like location, EV charging status, and remote locking/unlocking, facilitating seamless interactions between users and their cars.
Aquabyte
Venture Round in 2022 
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.
Korro Bio
Series B in 2022 
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.
Mojo Vision
Series B in 2022 
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.
InCarey is a Shanghai-based company founded in 2011 that specializes in developing a comprehensive medical service platform focused on the management of chronic and vertical diseases. The platform integrates medical, pharmaceutical, and insurance resources to provide a one-stop solution for patients requiring long-term care and support. InCarey's cloud-based online platform facilitates professional disease management services, allowing for direct interaction between doctors and patients. Additionally, it includes an e-commerce component that enables users to conveniently access medications for various chronic conditions. The company is dedicated to enhancing the patient experience through innovative payment services and a holistic approach to chronic disease management.
Yumi is a company that specializes in providing science-based meal delivery services for infants and young children. It focuses on producing fresh, nutrient-dense, and low-sugar baby food designed to meet the dietary needs of various age groups. Yumi aims to help parents understand the nutritional value of what they are feeding their children, particularly during the crucial early years of development. By offering a convenient and health-oriented solution, Yumi supports parents in ensuring their children receive optimal nutrition for brain development and overall well-being.
Forethought Technologies
Series C in 2021 
Founded in 2017, Forethought Technologies develops AI models for question-answering and information retrieval, embedding them into employee workflows. Its flagship product, Agatha Answers, is a smart agent that enhances customer support teams' efficiency by resolving common queries instantly.
Pair Eyewear
Series B in 2021 
Pair Eyewear, Inc. is a New York-based company that specializes in customizable eyeglasses for children. Founded in 2017 by Nathan Kondamuri and Sophia Edelstein, the company offers a unique approach to eyewear by providing base frames and interchangeable top frames that allow kids to express their personal style and interests. By combining functionality with creativity, Pair Eyewear transforms glasses from mere medical devices into a fun and engaging accessory for children. The company's direct-to-consumer model leverages an e-commerce platform, making the purchasing process convenient for parents while enhancing the overall experience for young wearers. Pair Eyewear is committed to offering quality, affordable glasses that are both stylish and practical, featuring hand-polished frames and shatterproof polycarbonate lenses.
UNION POS specializes in developing UNION TAB, a customizable iPad-based point of sale software tailored for bars and restaurants. Established in 2009 and headquartered in Austin, Texas, UNION POS focuses on meeting the unique needs of high-volume, high-touch venues. Their system offers a fast and intuitive interface that simplifies reporting and operational processes, allowing users to dedicate more time to customer engagement. The software includes features such as inventory management and loyalty programs, all supported by 24/7 live assistance and competitive processing fees. UNION POS aims to create a seamless experience that enhances operational efficiency while enabling businesses to concentrate on delivering exceptional service.
Jiandanxinli (aka Simple Psychology)
Series B in 2021 
Simple psychology belongs to Beijing Zhujian Technology Co., Ltd. Simple psychology focuses on providing high-quality psychological services.
Anyscale develops and operates distributed programming platforms for simplifying distributed AI development. It offers Ray, an open-source framework enabling software developers and machine learning engineers to scale applications effortlessly from a laptop to the cloud.
Block Renovation
Series C in 2021 
Block Renovation operates a renovation platform that unites design, sourcing, and construction within a single process to simplify home makeovers. The company combines architect-grade design, construction labor, and materials into a streamlined experience, enabling homeowners to plan, design, and build renovations with greater certainty around outcomes, quality, price, and timeline. By integrating design, sourcing, and project management under one roof, Block Renovation aims to improve the renovation journey for homeowners and provide contractors with a clearer, more efficient workflow.
Contra is a networking platform founded in 2019 by Ben Huffman and Gajus Kuizinas. It connects independent professionals with flexible work opportunities through an exclusive community, enabling freelancers to earn a living on their own terms.
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.
Stride Health
Series C in 2021 
Stride Health, Inc. is a health benefits platform that specializes in providing affordable health coverage options for independent workers and part-time employees in the United States. The company offers a range of services, including dental plans, doctor and prescription insurance plans, and various health coverage options tailored to meet the needs of its customers. Stride Health simplifies the enrollment process by guiding users through selecting the most cost-effective health plans, aiming to optimize their tax benefits and enhance their take-home pay. Founded in 2013 and based in San Francisco, California, the company was previously known as Covered, Inc. and rebranded to Stride Health, Inc. in March 2013. Stride Health also provides personal advisory services to assist clients in navigating the complexities of their health insurance options.
Embrace is a developer of a unified observability and error monitoring platform that enables engineers to effectively manage the complexities of mobile applications. The platform provides comprehensive insights by allowing users to access detailed behavioral and technical context, helping teams identify and prioritize issues instantly. Embrace empowers engineers to track user sessions, monitor activities, and analyze data related to app performance, including every view, tap, network request, and memory usage. By eliminating fragmented solutions and guesswork, Embrace enhances the ability of companies to resolve issues quickly and optimize mobile experiences, ultimately fostering the development of better and more impactful mobile applications.
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.
Inkitt operates an online community for writers and readers, offering a platform where authors can share and refine their work while gaining insights from readers. The company uses data-driven approaches to identify popular stories and publishes them across various media, aiming to create blockbuster franchises similar to Disney's model.
Sisu is a decision intelligence engine that allows users to efficiently and comprehensively utilize their cloud data. Companies such as Mastercard, Autodesk, Samsung, Upwork, Wayfair, Equinox, Udacity, and Gusto leverage Sisu to enhance their customer experiences, increase revenue growth, and reduce incident rates.
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.
Allay Therapeutics
Series C in 2021 
Allay Therapeutics is pioneering ultra-sustained pain therapeutics to transform post-surgical pain management. Its proprietary platform combines non-opioid analgesics and biopolymers to create dissolvable therapeutics delivering pain relief within targeted sites over weeks, significantly longer than current treatments. The company's lead product candidate, ATX101, is in Phase 2 clinical trials for total knee replacement surgeries.
Rapid Robotics
Series B in 2021 
Rapid Robotics is a provider of industrial automation solutions focused on robotic arms and palletizing systems for manufacturing and logistics. The company develops and deploys affordable robotic workcells and software that combine AI and vision-based capabilities to handle a range of palletizing and material-handling tasks. Its offerings enable rapid deployment, often in hours rather than weeks, and aim to lower operating costs while increasing production capacity, efficiency, and quality. Through a Robot-as-a-Service model, Rapid Robotics helps sites scale automation without the burden of ownership or extensive custom programming. Founded in 2019 and headquartered in San Francisco, the company targets manufacturers facing labor shortages and rising fulfillment complexity by delivering flexible, service-driven automation that improves margins and throughput.
Tulip Interfaces
Series C in 2021 
Tulip Interfaces is a technology company that creates shop‑floor applications for the manufacturing sector. Its no‑code platform integrates sensor data, digital work instructions, real‑time visualization, and operator inputs to connect existing equipment and streamline operations. The solution is used by firms in consumer electronics, pharmaceuticals, apparel, medical devices, aerospace, defense, automotive, and contract manufacturing to improve productivity, quality, and operational visibility. Founded in 2012, the company is headquartered in Somerville, Massachusetts.
Woebot Health
Series B in 2021 
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.
Block Renovation
Series B in 2021 
Block Renovation operates a renovation platform that unites design, sourcing, and construction within a single process to simplify home makeovers. The company combines architect-grade design, construction labor, and materials into a streamlined experience, enabling homeowners to plan, design, and build renovations with greater certainty around outcomes, quality, price, and timeline. By integrating design, sourcing, and project management under one roof, Block Renovation aims to improve the renovation journey for homeowners and provide contractors with a clearer, more efficient workflow.
Shape Therapeutics
Series B in 2021 
Shape Therapeutics, Inc. is a biotechnology company focused on RNA-editing gene therapy for various medical conditions, including neurodegenerative disorders, oncology, metabolic diseases, and rare genetic disorders. Founded in 2018 and headquartered in Seattle, Washington, the company utilizes its proprietary RNAfix technology to edit RNA using the body’s natural cellular machinery. This approach minimizes risks associated with immunogenicity, cellular toxicity, and unintended DNA editing. Shape Therapeutics is dedicated to advancing its innovative platforms for payload, delivery, and manufacturing to enable the development of effective treatments, aiming to address critical health challenges and improve patient outcomes.
Spiras Health
Series B in 2021 
Spiras Health operates a healthcare service that delivers specialized care to patients' homes for those managing complex chronic conditions. Their multidisciplinary clinical team offers services enhanced by telehealth, digital communications, and remote monitoring, aiming to improve patients' quality of life and reduce unnecessary hospitalizations.
ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.
Founded in 2014, Metabase is an open-source analytics and business intelligence application that enables users to create dashboards and share insights. Its platform offers professional services such as managed hosting and custom implementation assistance.
Aetion is a New York‑based company that builds a real‑world evidence platform. It aggregates claims, electronic health records, registries and clinical trial data to generate analytics that help payers, providers, biopharma and medical device firms assess the effectiveness and value of treatments. The platform’s rapid‑cycle analytics enable real‑time collaboration between payers, providers and life‑science companies, supporting value‑based care decisions. Founded in 2012 by Harvard Medical School faculty and data scientists, it has partnerships with McKesson and receives backing from major venture investors. The platform is used worldwide by health‑economists, epidemiologists and biostatisticians for database analytics and comparative‑effectiveness research.
Timescale
Series B in 2021 
Timescale develops an open-source time-series SQL database, TimescaleDB, designed for scale and complex queries. It integrates directly into query planning and execution engines to optimize performance, enabling clients to organize, store, analyze, and interpret time-series and machine data.
Affinia Therapeutics
Series B in 2021 
Affinia Therapeutics develops adeno-associated virus (AAV) gene therapies for muscular and central nervous system diseases. The company uses an AAV vector design platform built on synthetic and systems biology, high-throughput screening, and tissue- and single-cell-resolution analyses to create vectors with improved properties. It leverages sequencing, artificial intelligence, and structural modeling to enable rational design of therapies. Headquartered in Waltham, Massachusetts, Affinia Therapeutics was founded in 2019 and targets diseases with significant unmet needs in muscle and CNS.
Genies empowers individuals to create personalized digital avatars for expression across social media and messaging platforms. It offers tools for users to design avatars, avatar fashion lines, worlds, and interactive experiences, enabling brands to drive engagement through exclusive digital goods.
Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.
Arcellx is a clinical-stage biotechnology company developing immunotherapies and cell therapies for cancer and other serious diseases. It seeks to make cell therapies safer, more effective, and more broadly accessible. Its lead candidate CART-ddBCMA is in a Phase 1 trial for relapsed or refractory multiple myeloma and has FDA Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy designations. The company is also advancing ARC-SparX, a dosable and controllable CAR-T platform, into clinical programs ACLX-001 for relapsed or refractory multiple myeloma and ACLX-002 for relapsed or refractory acute myeloid leukemia. Arcellx's pipeline covers multiple myeloma, acute myeloid leukemia, and other cancer indications, with research extending into additional oncology areas and other serious diseases.
Cleo Labs, Inc. is a family support platform that offers pregnancy consultancy and parenthood guidance services to working parents. The company provides a range of consultation services, including lactation support, birth preparation, child wellness, and sleep consulting, as well as career coaching and immediate post-birth assistance. Cleo's mobile application connects families with certified care practitioners, facilitating their journey from fertility through parenting children up to age five. By partnering with employers, Cleo aims to enhance workplace culture, improve employee retention, and foster diverse and inclusive environments. The company operates globally, serving clients in over 50 countries and has collaborated with notable organizations such as eBay and LinkedIn. Founded in 2016 and headquartered in San Francisco, Cleo was previously known as Instacare Group, Inc. before rebranding in 2018.
Strive Health
Series B in 2021 
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.
Monte Rosa Therapeutics
Series C in 2021 
Monte Rosa Therapeutics is a biotechnology company focused on cancer therapeutics that target protein degradation pathways. It specializes in developing molecular glue degraders, a class of small molecules that direct disease-relevant proteins to degradation by the cell's natural machinery. The company uses its QuEEN platform, incorporating artificial intelligence and proprietary experimental tools, to identify target proteins for degradation by molecular glue degraders. It maintains a diverse library of more than 50,000 molecules and advancing its pipeline, including MRT-2359, a candidate that targets the translation termination factor GSPT1 for potential use in MYC-driven tumors.
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.
Burrow, Inc. is a New York-based company that designs, manufactures, and supplies luxury furniture for residential use. Founded in 2016, Burrow specializes in creating easy-to-move and customizable seating options such as sofas, sectionals, loveseats, and armchairs, as well as tables, rugs, and various accessories. The furniture is crafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow aims to provide customers with comfortable and stylish furnishing alternatives while avoiding traditional retail markups. The company operates showrooms in several states, including Washington, Massachusetts, Texas, and California, and also sells its products online. Additionally, Burrow has a manufacturing facility located in Mexico City, Mexico.